Form 4 for GDRX GoodRx Holdings, Inc.
Accepted 2021-10-12 00:00:00 ET · period of report 2021-10-07 · accession 0000899243-21-039976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-12 | 2021-10-07 | GDRX | NAGJI BANSI | Pres, Healthcare | M - OptEx | $6.84 | +3,600 | 32.8K | +12% | +$24.6K |
| D | 2021-10-12 | 2021-10-07 | GDRX | NAGJI BANSI | Pres, Healthcare | S - Sale+OE | $45.05 | -3,600 | 29.2K | -11% | -$162.2K |
| D | 2021-10-12 | 2021-10-07 | GDRX | NAGJI BANSI | Pres, Healthcare | M - OptEx | $0.00 | -3,600 | 3,600 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-10-07 | M | A | 3,600 | $6.84 | 32,766 | D | — | — | |
| 2 | Common | Class A Common Stock | 2021-10-07 | S | D | 3,600 | $45.05 | 29,166 | D | — | — | (F2) This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.18. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-10-07 | M | D | 3,600 | $0.00 | 3,600 | D | $6.84 · — to 2030-06-15 | 3,600 Class A Common Stock | (F4) The Reporting Person's prior Form 4 filed on September 16, 2021 incorrectly stated that 309,564 shares underlying this option remained after the reported transactions and should have reported 309,584 shares underlying this option after the reported transactions. (F3) The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024. |